<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03627455</url>
  </required_header>
  <id_info>
    <org_study_id>TROPDM2GENDER</org_study_id>
    <nct_id>NCT03627455</nct_id>
  </id_info>
  <brief_title>Troponin I and T and Adverse Outcomes in Patients With and Without Diabetes Mellitus After Coronary Intervention</brief_title>
  <official_title>A Sex-specific Analysis of the Predictive Value of Troponin I and T in Patients With and Without Diabetes Mellitus After Successful Coronary Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wilhelminenspital Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Association for the Promotion of Research in Atherosclerosis, Thrombosis and Vascular Biology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Wilhelminenspital Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Elevated levels of troponin are associated with future MACE. Data on the prognostic value of
      high sensitive troponin T (hs-TnT) as compared to high sensitive troponin I (hs-TnI) in
      diabetic and non-diabetic patients are sparse.

      We aimed to assess the risk for MACE according to gender and diabetes status and to compare
      the prognostic value of hs-TnT and hs-TnI with regards to clinical outcomes in diabetic and
      non-diabetic patients undergoing percutaneous coronary intervention (PCI).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2003</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>MACE</measure>
    <time_frame>8 years</time_frame>
    <description>All-cause death, non-fatal myocardial infarction, non-fatal stroke</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">818</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Male, with DM</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Male, without DM</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Female, with DM</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Female, without DM</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Percutaneous coronary intervention</intervention_name>
    <description>Percutaneous coronary intervention</description>
    <arm_group_label>Female, with DM</arm_group_label>
    <arm_group_label>Female, without DM</arm_group_label>
    <arm_group_label>Male, with DM</arm_group_label>
    <arm_group_label>Male, without DM</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        all patients undergoing percutaneous coronary intervention at the department of cardiology
        at the Wihelminenspital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Percutaneous coronary intervention

        Exclusion Criteria:

          -  unsuccessful percutaneous coronary intervention
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 8, 2018</study_first_submitted>
  <study_first_submitted_qc>August 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 13, 2018</study_first_posted>
  <last_update_submitted>August 11, 2018</last_update_submitted>
  <last_update_submitted_qc>August 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wilhelminenspital Vienna</investigator_affiliation>
    <investigator_full_name>Maximilian Tscharre, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

